Federal Health Grants

Addressing the Impact of Syndemics on the Health of People with HIV and Diseases and Conditions within the Missions of NIDDK and NHLBI (R01 Clinical Trial Optional)

This funding opportunity is designed to support non-profit organizations in expanding and implementing proven falls prevention programs for older adults, focusing on effective strategies for broader adoption within community and clinical settings.

The United States Agency for International Development (USAID) is seeking applications for a fixed amount award cooperative agreement from qualified entities to implement the Ensuring Accessibility to Quality HIV Services (SAPA) in Kazakhstan. Eligibility for this award is restricted to qualified local organizations. USAID intends to make an award to the applicant(s) who best meets the objectives of this funding opportunity based on the merit review criteria described in this NOFO subject to a risk assessment. Eligible parties interested in submitting an application are encouraged to read this NOFO thoroughly to understand the type of program sought, application submission requirements and selection process. To be eligible for award, the applicant must provide all information as required in this NOFO and meet eligibility standards in Section C of this NOFO. This funding opportunity is posted on www.grants.gov, and may be amended. It is the responsibility of the applicant to regularly check the website to ensure they have the latest information pertaining to this notice of funding opportunity and to ensure that the NOFO has been received from the internet in its entirety. USAID bears no responsibility for data errors resulting from transmission or conversion process. To be eligible for award the applicant must enroll an account in the System for Award Management (SAM), as explained in Section D. The registration process may take many weeks to complete. Therefore, applicants are encouraged to begin registration early in the process. Please send any questions to the point(s) of contact identified in Section D. The deadline for questions is shown in the NOFO. Responses to questions received prior to the deadline will be furnished to all potential applicants through an amendment to this notice posted to www.grants.gov. Issuance of this notice of funding opportunity does not constitute an award commitment on the part of the Government nor does it commit the Government to pay for any costs incurred in preparation or submission of comments/suggestions or an application. Applications are submitted at the risk of the applicant. All preparation and submission costs are at the applicants expense. Thank you for your interest in USAID programs.

This funding opportunity provides financial support for researchers to conduct secondary analyses of existing vision-related datasets to explore new scientific ideas and improve understanding of eye health and diseases.

This funding opportunity supports the development of innovative research infrastructure to advance interdisciplinary studies on aging, encouraging collaborations that address complex aging-related issues and health disparities, particularly among women.

The purpose of this notice of funding opportunity (NOFO) is to support basic and exploratory research projects to advance our understanding of T. pallidum bacterial pathogenesis.

This funding opportunity supports innovative projects that develop new technologies for recording and modulating neural activity, aimed at enhancing our understanding of the nervous system through live-animal experimentation.

This grant provides financial support for early-career researchers in dental, oral, and craniofacial fields to receive mentorship and develop their research skills, with a focus on enhancing diversity in the research workforce.

This funding opportunity provides financial support to state and local governments, tribal organizations, and other political subdivisions to conduct health assessments and implement strategies that reduce exposure to hazardous substances and promote environmental public health.

The purpose of this program is to implement screening, brief intervention, and referral to treatment services for children, adolescents, and/or adults in primary care and community health settings (e.g., health centers, hospital systems, health maintenance organizations (HMOs), preferred-provider organizations (PPOs), Federally Qualified Health Care (FQHC) systems, behavioral health centers, pediatric health care providers, Childrens Hospitals, etc.) with a focus on screening for underage drinking, opioid use, and other substance use.

This funding opportunity is designed to enhance Pakistan's ability to prevent and respond to infectious diseases by improving health coordination, surveillance systems, and emergency response capabilities, initially focusing on Sindh Province.

This funding opportunity provides $1 million to support a national coordinating center that will enhance collaboration, education, and research initiatives in nonmalignant hematology, targeting a diverse range of eligible institutions.

The "Ending the HIV Epidemic in the U.S. Ryan White HIV/AIDS Program Parts A and B" grant aims to reduce new HIV infections in the U.S. by focusing resources on the most affected areas and implementing strategies for early diagnosis, effective treatment, prevention, and rapid response to outbreaks, while also improving access to care and support services for those diagnosed with HIV.

This funding opportunity supports community-driven research projects that assess environmental exposures and develop public health interventions to address health disparities in affected communities.

This grant provides funding for innovative research on immune mechanisms at mucosal surfaces in the respiratory, gastrointestinal, and urogenital tracts, aimed at advancing the understanding of mucosal immunology.

This funding opportunity provides financial support for institutions and organizations to create and manage a resource that supplies human tissues and organs for biomedical research, benefiting studies on various diseases and health conditions.

This funding opportunity provides financial support to small businesses and organizations developing innovative medical technologies and digital health solutions to improve health outcomes.

This funding opportunity announcement (FOA) is a reissue due to an omission of TRAINING RECORD review questions in Section V. This FOA encourages applications for the Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) D43 program for institutional research training programs in low-and middle-income countries (LMICs, as defined by the World Bank classification system). Applications may be for collaborations between institutions in the U.S and an eligible LMIC or may involve just LMIC institutions if there is a previous track record of externally funded research and/or research training programs by the lead LMIC institution. The proposed institutional research training program is expected to sustainably strengthen the NCD research capacity of the LMIC institutions, and to train in-country experts to develop and conduct research on NCDs across the lifespan, with the long-range goal of developing and implementing evidence-based interventions relevant to their countries. The main focus of research training covered in the application must be relevant to the interests of at least one of the participating NIH ICs as stated by each in this FOA. Other NCD topics may be included as secondary and complementary focus areas. This Funding Opportunity Announcement (FOA) allows support of trainees as the lead investigator of an independent clinical trial; or a separate ancillary study to an existing trial; or to gain research experience in a clinical trial led by another investigator, as part of their research and career development.

The "Mechanisms of Inducing HIV Immunity in Early Life (MIEL)" grant is a funding opportunity that supports research aimed at understanding and developing methods to establish and maintain immunity against HIV in children from birth to less than 12 years old, with a focus on the use of vaccines and antibodies, and the influence of maternal factors and vaccine adjuvants.

This funding opportunity supports researchers exploring the ethical, legal, and social issues related to human genetic and genomic research, particularly as these technologies become more integrated into healthcare and society.